Perioperative Myocardial Injury/Infarction After Cardiac Surgery: The Diagnostic Criteria Need to Change.

Competing Interests: Funding Support and Author Disclosures Dr Devereaux is a member of a research group with a policy of not accepting honoraria or other payments from industry for personal financial gain; they do accept honoraria/payments from industry to support research endeavors and costs to participate in meetings; based on study questions he originated and grants he has written, he has received grants from Abbott Diagnostics, AOP, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Cloud DX, Coviden, Octapharma, Philips Healthcare, Roche Diagnostics, Roche, Siemens, Stryker, and Trimedic; has participated in advisory board meetings for GlaxoSmithKline, Bayer, Quidel Canada, and Trimedic; has participated in expert panel meetings with AstraZeneca, Boehringer Ingelheim, and Roche; and has participated in international meetings with AOP. Dr Whitlock has received grants from Boehringer Ingelheim, Abbott, Atricure, Cytosorbents, and Roche; and has received honoraria from Atricure, Bayer, Artivian, Edwards Lifesciences, Phasebio, and LeMaitre. Dr Lamy has reported that he has no relationships relevant to the contents of this paper to disclose.